Table: Kyorin Pharmaceutical -2023/24 parent results

Kyorin Pharmaceutical

10/05/2024 07:00

May 10 (Reuters)- 
          Kyorin Pharmaceutical Co., Ltd. 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to     NEXT     
              Mar 31, 2024    Mar 31, 2023   Mar 31, 2025     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales          105.16           5.85          107.80        49.30    
                               (-11.0 pct)    (+2.5 pct)    (+3.4 pct) 
  Operating        6.68           3.06            7.00         1.40    
              (+118.3 pct)     (-24.4 pct)    (+4.8 pct)   (-17.2 pct) 
  Recurring        7.42           2.98            7.60         1.70    
              (+149.3 pct)     (-24.9 pct)    (+2.5 pct)   (-20.1 pct) 
  Net             53.00           3.01            5.50         1.20    
                               (-23.3 pct)    (-89.6 pct)  (-97.6 pct) 
  EPS          923.33 yen       51.78 yen      95.73 yen    20.89 yen  
  Ann Div       52.00 yen       52.00 yen      52.00 yen               
  -Q2 Div       20.00 yen       20.00 yen      20.00 yen               
  -Q4 Div       32.00 yen       32.00 yen      32.00 yen               
  
  NOTE - Kyorin Pharmaceutical Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4569.T